YK-029A
Catalog No.
BA6349
YK-029A is an orally effective mutation inhibitor.
Featured Products
YK-029A is an orally effective mutation inhibitor targeting T790M mutations (EGFR) and exon 20 insertion mutations (EGFRex20ins).YK-029A induces tumor regression in a driven PDX model and has antitumor activity.
Physical Appearance | A solid |
Storage | -20°C |
M.Wt | 500.60 |
Cas No. | 2064269-82-3 |
Formula | C27H32N8O2 |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |